|
|
Safe Medical Devices Act (SMDA) |
|
515(i) Reclassification Letter to Manufacturers |
|
|
SMDA Changes - PMA Manual Insert |
|
|
|
SMDA Changes - Premarket Notification; Regulatory Requirements for Medical Devices (510k) Manual Insert |
|
|
|
Safety Alerts, Public Health Advisories and Notices |
|
FDA Warning Letters Database |
|
|
Health Advisories and Safety Alerts |
|
|
Product Recalls, Alerts, and Warnings |
|
|
SARS |
|
FTC and FDA Crackdown on Internet Marketers of Bogus SARS Prevention Products |
|
|
SARS Diagnostics: Scientific and Regulatory Challenges Workshop - July 14, 2003 - Presentations and Transcript |
|
|
Severe Acute Respiratory Syndrome (SARS) |
|
|
Satellite Videoconferencing |
|
Division of Communication Media |
|
|
Scanning |
|
Whole Body Scanning Using Computed Tomography (CT) |
|
|
Scarring |
|
CosmoDerm™ 1 Human-Based Collagen, CosmoDerm™ 2 Human-Based Collagen and CosmoPlast™ Human-Based Collagen |
|
|
Science Review |
|
Science at Work in CDRH: A Report on the Role of Science in the Regulatory Process; Final Report |
|
|
|
Scoliosis |
|
Reducing Patient Exposure During Scoliosis Radiography |
|
|
Scorecards |
|
Scorecard Reports |
|
|
Sealer |
|
Guide for Submission of Information on Industrial Radiofrequency Dielectric Heater and Sealer Equipment Pursuant to 21 CFR 1002.10 and 1002.12 (FDA 81-8137) |
|
|
|
Sexual Therapy Devices |
|
FDA Clears New Female Sexual Therapy Device |
|
|
Sexually Transmitted Disease (STD) Protection |
|
Letter - Manufacturers, Importers, and Repackagers of Condoms for Contraception or Sexually-Transmitted Disease Prevention (Holt) |
|
|
|
Prospective Manufacturers of Barrier Devices used during Oral Sex for STD Protection |
|
|
|
Sexually Transmitted Diseases (STDs) |
|
FDA Approves Expanded Use of HPV Test |
|
|
On the Teen Scene: Preventing STDs |
|
|
Sharps |
|
Guidance on the Content and Format of Premarket Notification [510(k)] Submissions for Sharps Containers |
|
|
|
Manufacturers and Initial Distributors of Sharps Containers and Destroyers Used by Health Care Professionals |
|
|
|
NeedleZap |
|
|
Premarket Approval Applications (PMA) for Sharps Needle Destruction Devices; Final Guidance for Industry and FDA |
|
|
|
Supplementary Guidance on Premarket Notifications for Medical Devices with Sharps Injury Prevention Features; Guidance for Industry and FDA |
|
|
|
Sheaths |
|
Guidance for Manufacturers Seeking Marketing Clearance of Ear, Nose, and Throat Endoscope Sheaths Used as Protective Barriers; Final |
|
|
|
Shelf Life |
|
Shelf Life of Medical Devices |
|
|
|
Shunts |
|
Shunt Technology: Challenges and Emerging Directions |
|
|
|
SIDS (Sudden Infant Death Syndrome) |
|
Letter: Medical Claims on Labeling and Promotional Materials of Infant Mattresses and Infant Positioners Distributed in the United States |
|
|
|
Silicone |
|
Breast Implants Information |
|
|
Guidance for Saline, Silicone Gel, and Alternative Breast Implants; Guidance for Industry and FDA |
|
|
|
Study of Silicone Gel Breast Implant Rupture, Extracapsular Silicone, and Health Status in a Population of Women |
|
|
|
Single Use Devices |
|
FDA Talk Paper: FDA Revises Guidance on Reprocessing of Single-Use Devices |
|
|
Single Use Devices - See Reuse |
|
|
|
Sirolimus |
|
Guidance for Industry and FDA Staff; Class II Special Controls Guuidance Document: Sirolimus Test Systems |
|
|
|
Site Visits |
|
ODE Site Visit Program |
|
|
Six Year Rule |
|
Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997 |
|
|
|
Skin |
|
Cyanoacrylate Tissue Adhesive for the Topical Approximation of Skin - Premarket Approval Applications (PMAs) - Guidance for Industry and FDA Staff |
|
|
|
FDA Approves Adhesive for Skin Wound Closure |
|
|
Premarket Notification [510(k)] Submissions for Testing for Skin Sensitization to Chemicals in Natural Rubber Products; Final |
|
|
|
Skin Fillers |
|
FDA Approves Sculptra for HIV Patients |
|
|
Sleep Apnea |
|
Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA |
|
|
|
Small Business |
|
FDA 3602 - FY2004 MDUFMA Small Business Qualification Certification |
|
|
|
FY 2005 MDUFMA Small Business Qualification Worksheet and Certification - Guidance for Industry and FDA |
|
|
|
Reduction of Civil Money Penalties for Small Entities; Guidance for Industry and FDA Staff |
|
|
|
Small Business Guide to FDA (FDA 96-1092) |
|
|
Snoring |
|
Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA |
|
|
|
Software |
|
Computer Aided Diagnosis - Open Public Workshop Meeting Summary |
|
|
Computer-Controlled Potentially High-Risk Medical Devices - List of Device Types |
|
|
Computerized Systems Used in Clinical Trials |
|
|
|
FDA Policy For The Regulation Of Computer Products (DRAFT) |
|
|
|
General Principles of Software Validation; Final Guidance for Industry and FDA Staff |
|
|
|
Glossary of Computerized System and Software Development Terminology, August 1995 |
|
|
Guidance for Off-the-Shelf Software Use in Medical Devices; Final |
|
|
|
Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices; Final |
|
|
|
Review of 510(k)s for Computer Controlled Medical Devices #K91-1 (blue book memo) |
|
|
Y2K Issue for Production Processes and Quality System Software |
|
|
|
Solid |
|
Guidance for the Submission of 510(k)s for Solid State X-ray Imaging Devices; Final |
|
|
|
Spanish Language Publications |
|
Mejor Cuidado de la Salud Con Dispositivos Médicos de Calidad: FDA a la Cabeza en Tecnología de Dispositivos Médicos |
|
|
Spanish Language Brochures |
|
|
Spectacle Frames |
|
Sunglasses, Spectacle Frames, Spectacle Lens and Magnifying Spectacles |
|
|
Spectacle Lens |
|
Sunglasses, Spectacle Frames, Spectacle Lens and Magnifying Spectacles |
|
|
Spinal |
|
Complications Related to the Use of Bone Cement in Treating Compression Fractures of the Spine - FDA Public Health Web Notification |
|
|
|
FDA Approves New Spinal Fusion Device |
|
|
Guidance Document for the Preparation of IDEs for Spinal Systems |
|
|
|
Spinal System 510(k)s - Guidance for Industry and FDA Staff |
|
|
|
Staff |
|
Center for Devices and Radiological Health - Organizational Structure |
|
|
|
Center for Devices and Radiological Health - Referral List |
|
|
Stakeholder Information |
|
CDRH Stakeholder Information |
|
|
STAMP |
|
Shunt Technology: Challenges and Emerging Directions |
|
|
|
Standards Program |
|
CDRH Standard Operating Procedures for the Identification and Evaluation of Candidate Consensus Standards for Recognition; Final Guidance for Industry |
|
|
|
CDRH Standards Program |
|
|
Frequently Asked Questions on the Recognition of Consensus Standards; Guidance for Industry and for FDA Staff |
|
|
|
Guidance on the Use of Standards in Substantial Equivalence Determinations; Final |
|
|
|
Opportunity to Recommend Standards for CDRH Recognition |
|
|
Recognition and Use of Consensus Standards; Final Guidance for Industry and FDA |
|
|
|
Required Elements for a Declaration of Conformity to a Recognized Standard - (Screening Checklist for All Premarket Notification [510(k)] Submissions) |
|
|
|
Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing' (Replaces #G87-1 #8294) (blue book memo) |
|
|
Statistics |
|
Perspectives on Clinical Studies for Medical Device Submissions (Statistical) |
|
|
|
PMA Review Statistical Checklist |
|
|
|
Statistical Aspects of Submissions to FDA: A Medical Device Perspective (also includes as Appendix the article Observed Uses and Abuses of Statistical Procedures in Medical Device Submissions |
|
|
|
Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests; Draft Guidance for Industry and FDA Reviewers |
|
|
|
Stents |
|
Dear Colleague Letter: NIR ON Ranger w/SOX Premounted Stent System |
|
|
Draft Guidance for the Clinical Investigation of Urethral Stents |
|
|
|
Drug-Eluting Cardiovascular Stents - Request for Designation |
|
|
FDA Advises Physicians of Adverse Events Associated with Cordis Cypher Coronary Stents (FDA Talk Paper) |
|
|
FDA Approves Drug-Eluting Stent for Clogged Heart Arteries |
|
|
FDA Approves Stent for Urinary Obstruction in Men |
|
|
FDA Approves Two New Devices to Help Reduce the Risk of Repeat Coronary Stent Re-Narrowing (In-Stent Restenosis) |
|
|
FDA Public Health Notification: Updated Data on Mortality Associated with Medtronic AVE AneuRx® Stent Graft System |
|
|
|
FDA Public Health Web Notification: Information for Physicians on Sub-acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Coronary Stent |
|
|
|
Frequently Asked Questions About Problems With Endovascular Grafts for Treatment of Aortic Abdominal Aneurysms (AAA) |
|
|
Guidance for the Content of Premarket Notifications for Metal Expandable Biliary Stents; Final |
|
|
|
Guidance for the Content of Premarket Notifications for Ureteral Stents |
|
|
Summary of October 2002 Advisory Meeting to Discuss Approval of Drug Coated Stent |
|
|
Sterilants/High Level Disinfectants |
|
Ethylene Oxide; Ethylene Chlorohydrin; and Ethylene Glycol; Proposed Maximum Residue Limits and Maximum Levels of Exposure |
|
|
|
Sterilants and High Level Disinfectants Cleared by FDA in a 510(k) with General Claims for Processing Reusable Medical and Dental Devices |
|
|
Sterility |
|
Application of the Device Good Manufacturing Practice (GMP) Regulation to the Manufacture of Sterile Devices |
|
|
|
Dental Handpiece Sterilization (Dear Doctor Letter) |
|
|
|
Guidance ('Guidelines') for Evaluation of Hysteroscopic Sterilization Devices |
|
|
|
Guideline on Sterile Drug Products Produced by Aseptic Processing |
|
|
|
ORDB 510(k) Sterility Review Guidance |
|
|
|
Premarket Notification [510(k)] Submissions for Medical Sterilization Packaging Systems in Health Care Facilities; Draft Guidance for Industry and FDA |
|
|
|
Updated 510(k) Sterility Review Guidance K90-1; Final Guidance for Industry and FDA |
|
|
|
Sterilization Devices |
|
FDA Approves New Female Sterilization Device |
|
|
Sterilizers |
|
Addendum to: Guidance on Premarket Notification [510(k)] Submissions for Sterilizers Intended for Use in Health Care Facilities |
|
|
Ethylene Oxide; Ethylene Chlorohydrin; and Ethylene Glycol; Proposed Maximum Residue Limits and Maximum Levels of Exposure |
|
|
|
Guidance on Premarket Notification 510(k) for Sterilizers Intended for Use in Health Care Facilities |
|
|
|
New Policy Concerning PMA Postmarket Inspections of Contract Sterilizers |
|
|
|
Premarket Notification [510(k)] Submissions for Medical Sterilization Packaging Systems in Health Care Facilities; Draft Guidance for Industry and FDA |
|
|
|
Premarket Notifications [510(k)] for Biological Indicators Intended to Monitor Sterilizers Used in Health Care Facilities; Draft Guidance for Industry and FDA Reviewers |
|
|
|
Stimulator |
|
Consumer Alert on the Stimulator |
|
|
Consumer Information on Electronic Muscle Stimulators |
|
|
Draft 510(k) Checklist for Non-Implanted Electrical Stimulators Used for the Treatment of Urinary Incontinence |
|
|
|
Draft Premarket Notification Review Guidance for Evoked Response Somatosensory Stimulators |
|
|
|
Draft Version Guidance for Clinical Data to be Submitted for Premarket Approval Application for Cranial Electrotherapy Stimulators |
|
|
|
FDA Approves Expanded Use of Brain Implant for Parkinson's Disease |
|
|
FDA Approves Implanted Brain Stimulator to Control Tremors |
|
|
FDA Public Health Notification: Diathermy Interactions with Implanted Leads and Implanted Systems with Leads |
|
|
|
FDA Talk Paper: Scheme to Sell Gas Grill Igniters for Pain Relief Backfires; Court Orders Refund to Purchasers |
|
|
Guidance Document for Industry and CDRH staff for the Preparation of Investigational Device Exemptions and Premarket Approval Applications for Bone Growth Stimulator Devices; Draft |
|
|
|
Guidance Document for Powered Muscle Stimulator 510(k)s; Final |
|
|
|
Guidelines for Reviewing Premarket Notifications that Claim Substantial Equivalence to Evoked Response Stimulators |
|
|
|
Important Information on Anti-Theft and Metal Detector Systems and Pacemakers, ICDs, and Spinal Cord Stimulators |
|
|
Neurological Devices Panel, March 31, 2000 - Bilateral Deep Brain Stimulator |
|
|
Stomach Band |
|
FDA Approves Implanted Stomach Band to Treat Severe Obesity |
|
|
Strategic Plan |
|
CDRH Strategic Plan |
|
|
FDA Launches Initiative to Improve the Development and Availability of Innovative Medical Products |
|
|
Improving Innovation in Medical Technology: Beyond 2002 |
|
|
Improving Innovation in Medical Technology: Beyond 2002 - Executive Summary |
|
|
Strategic Plan - Reducing Device Approval Times |
|
|
Strategic Planning: Taking Us Into the Future - September 2001 |
|
|
Studios |
|
Division of Communication Media |
|
|
Submerged (Underwater) Exercise Equipment |
|
Guidance Document for the Preparation of Premarket Notification [510(k)] Applications for Submerged (Underwater) Exercise Equipment |
|
|
|
Substantial Equivalence |
|
Substantial Equivalence (SE) Decision Making Documentation ATTACHED: 'SE' Decision Making Process (Detailed) i.e. the decision making tree |
|
|
|
Sunglasses |
|
Sunglasses, Spectacle Frames, Spectacle Lens and Magnifying Spectacles |
|
|
Sunlamps |
|
Compliance Program Guidance Manual: Field Implementation of the Sunlamp and Sunlamp Product Performance Standard, as amended; Final Guidance for Industry and FDA |
|
|
|
Exemption from Reporting and Record keeping Requirements for Certain Sunlamp Product Manufacturers |
|
|
|
Guide for Preparing Annual Reports on Radiation Safety Testing of Sunlamps and Sunlamp Products |
|
|
|
Guide for Preparing Product Reports on Sunlamps and Sunlamp Products (21-CFR 1002) |
|
|
|
Policy on Lamp Compatibility (sunlamps) |
|
|
|
Policy on Maximum Timer Interval and Exposure Schedule for Sunlamp Products |
|
|
|
Policy on Warning Label Required on Sunlamp Products |
|
|
|
Quality Control Guide for Sunlamp Products (FDA 88-8234) |
|
|
|
Surgeon's Gloves |
|
Draft Medical Glove Guidance Manual |
|
|
|
Premarket Approval Applications (PMA) for Absorbable Powder for Lubricating a Surgeon’s Glove - Guidance for Industry and FDA Staff |
|
|
|
Statement by Elizabeth D. Jacobson Acting Director CDRH, FDA, DHS, Before the Subcommittee on Oversight And Investigations Re: regulations of natural rubber latex gloves |
|
|
Surgeon's and Patient Examination Gloves; Reclassification and Medical Glove Guidance Manual Availability; Proposed Rule and Notice |
|
|
Surgical Drapes |
|
Guidance on Premarket Notification [510(k)] Submissions for Surgical Gowns and Surgical Drapes |
|
|
|
Surgical Gowns |
|
Guidance on Premarket Notification [510(k)] Submissions for Surgical Gowns and Surgical Drapes |
|
|
|
Surgical Lamps |
|
Guidance Document for Surgical Lamp 510(k)s; Final |
|
|
|
Surgical Masks |
|
Surgical Masks - Premarket Notification [510(k)] Submissions; Guidance for Industry and FDA |
|
|
|
Surgical Mesh |
|
FDA Public Health Web Notification: Counterfeit Polypropylene Mesh |
|
|
|
Guidance for the Preparation of a Premarket Notification Application for a Surgical Mesh; Final |
|
|
|
Surgical Staplers |
|
Surgical Stapler Information |
|
|
Synvisc/Hyalgan Knee Injection For Osteoarthritis |
|
Hyalgan |
|
|
Synvisc |
|
|
Syringes |
|
Guidance on the Content of Premarket Notification [510(K)] Submissions for Piston Syringes |
|
|
Supplementary Guidance on Premarket Notifications for Medical Devices with Sharps Injury Prevention Features; Guidance for Industry and FDA |
|
|
|